Uncategorized
MidEuropa marks 25 years of building industry champions out of Central Europe
MidEuropa is proud to celebrate 25 years of building regional and international champions out of Central Europe, and we would like to thank all our colleagues, investors, management teams, and network of experts and advisers, who have helped us work towards this mission for the last quarter century. Since our inception in 1999, we have…
Read MoreMidEuropa Completes Acquisition of Controlling Stake in FAMAR
MidEuropa, the leading private equity investor with deep roots in Central Europe, announces today that it has completed the acquisition of a controlling stake in FAMAR, a well-established pharmaceutical contract development and manufacturing organisation (CDMO), from ECM Partners and Metric Capital Partners. The current shareholders are reinvesting alongside MidEuropa and the Company’s management team. FAMAR…
Read MoreMidEuropa Acquires a Majority Stake in FAMAR
MidEuropa announces today that it has signed an agreement to acquire a controlling stake in FAMAR, a well-established pharmaceutical contract development and manufacturing organisation (CDMO), from ECM Partners and Metric Capital Partners. MidEuropa will invest alongside the management team and current shareholders, who will retain a minority stake. The transaction, which is subject to customary…
Read MoreMidEuropa’s Optegra bolsters its leading positioning through series of acquisitions
MidEuropa, the leading European private equity investor with deep roots in Central Europe, announces today that its portfolio company Optegra, a leading pan-European ophthalmology platform, has completed its 4th acquisition in Slovakia, becoming the undisputed market leader in less than 18 months. As one of Europe’s fastest growing ophthalmology providers, Optegra’s development over the past…
Read MoreRobert Knorr Wins 2024 Real Deals Mid-Cap PE Investment Leader Award
We are delighted to announce that Robert Knorr, Managing Partner at MidEuropa, has been recognised as the Mid-Cap Private Equity Investment Leader for 2024 at the Real Deals Private Equity Awards, the longest running and most prestigious such awards in Europe. The decision was made by an expert judging panel, which included a number of…
Read MoreMidEuropa’s Greenhouse Gas Emissions Reduction Targets Receive Validation from the Science Based Targets initiative
MidEuropa has received validation of our emissions reduction targets by the Science Based Target initiative (SBTi). These targets are consistent with the levels required to meet the Paris Agreement goals and limit warming to 1.5°C. Our targets: Commit to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year.…
Read MoreMidEuropa backs Symfonia’s first international acquisition to build true Pan-European champion
MidEuropa, the leading European private equity investor with deep roots in Central Europe, announces today the acquisition by its portfolio company Symfonia, a leading independent provider of accounting and payroll software solutions for Polish SMEs, of Softeh Plus, an ERP software provider in the Romanian Healthcare sector. This transaction marks Symfonia’s first foray outside of…
Read MoreMidEuropa Sells Profi To Ahold Delhaize For EUR1.3bn In Landmark Exit
MidEuropa, a leading European private equity investor with deep roots in Central Europe, today announces that it has entered into an agreement to sell Profi Rom Food (“Profi or the “Company”), one of Romania’s major food retailers, to Ahold Delhaize for an Enterprise Value of approximately EUR1.3 billion pre-IFRS16 (EUR1.8 billion post-IFRS 16). Profi is…
Read MoreMidEuropa Completes Partial Sale of Symfonia to Accel-KKR
MidEuropa, the leading private equity investor in Central Europe, announced today that it has completed the sale of a majority stake in Symfonia to Accel-KKR, a leading global technology investment firm focused on software and tech-enabled companies. MidEuropa will retain a significant minority stake in the business. MidEuropa acquired Symfonia in March 2021 in a…
Read MoreMidEuropa-Backed Symfonia Welcomes Accel-KKR Investment
MidEuropa, a leading investor in Central Europe, is pleased to announce the sale of a majority stake in Symfonia to Accel-KKR, a leading global technology investment firm focused on software and tech-enabled companies. Upon completion of the transaction, MidEuropa will retain a significant minority stake in the business, reflecting the firm’s strong conviction in Symfonia’s…
Read MoreMidEuropa Completes Acquisition of Majority Stake in Optegra
MidEuropa, the leading private equity investor in Central Europe, announced today that it has completed the acquisition of a majority stake in Optegra Eye Health Care (“Optegra” or the “Company”) from H2 Equity Partners, which is reinvesting alongside MidEuropa and the Company’s management team. Optegra is a leading European ophthalmology platform operating in Poland, Czech…
Read MoreMidEuropa Completes the Sale of Kent Hospital to Acibadem
MidEuropa, the leading private equity investor in Central Europe, announced today that it has completed the sale of Kent Health Group (“Kent” or the “Company”) to Acibadem Healthcare Group (“Acibadem”). Kent is the leading premium healthcare services provider in Izmir, Turkey, serving the entire Aegean region. Kent operates a 43,000 sqm, 340 bed flagship hospital…
Read More